Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Phase 1, Open-Label Study of ABSK021 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Solid Tumor
This is an open-label phase 1 study to determine the safety and tolebility of oral ABSK021 in patients with advanced solid tumor as well as the Recommended Pha…
NeoplasmsTenosynovial Giant Cell Tumor
Abbisko Therapeutics Co, LtdNCT04192344
A Long-term Study to Further Evaluate the Risk of Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
A study to evaluate the long-term risk of hepatic failure with TURALIO™ (pexidartinib) and the mechanism of liver injury based upon optional liver biopsy infor…
HepatotoxicityTenosynovial Giant Cell Tumor
Daiichi SankyoNCT04635111
Real-World Patient Experience of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor
The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participa…
Tenosynovial Giant Cell Tumor
Deciphera Pharmaceuticals, LLCNCT07075471